Alethia™ Pertussis 480750
Ref 480750
Alethia Pertussis 480750 is a bordetella pertussis nucleic acid IVD (EU IVDR Class C; FDA Class II; FDA product code OZZ, Bordetella Pertussis Dna Assay System) made by Meridian Bioscience Inc., registered in EUDAMED on 15 Sep 2026 (Basic UDI-DI 008407331ALETHIACLC011RE) and listed in FDA GUDID since 8 Jan 2019 (UDI-DI 00840733102226), active as of 8 Nov 2026.
Active
CE IVDR
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number008407331ALETHIACLC011RE 00840733102226 | Date15 Sep 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00840733102226 | Date8 Jan 2019 | StatusListed |
Official records
- EUDAMED public site 008407331ALETHIACLC011RE
- AccessGUDID record 00840733102226
From the FDA record
- Device description
- The Alethia Pertussis DNA Amplification Assay, performed on the Alethia Reader, is a qualitative in vitro diagnostic test for the direct detection of Bordetella pertussis in human nasopharyngeal swab samples taken from patients suspected of having respiratory tract infection attributable to Bordetella pertussis. The Alethia Pertussis assay utilizes loop-mediated isothermal DNA amplification (LAMP) technology to detect B. pertussis by targeting the IS481 insertional element of the B. pertussis genome. The IS481 insertional element can also be found in B. holmesii and some B. bronchiseptica strains. Respiratory infections with B. pertussis, B. holmesii or B. bronchiseptica may yield positive test results in IS481 assays. B. holmesii infection may cause clinical illness similar to B. pertussis, and mixed outbreaks involving both B. pertussis and B. holmesii infection have been reported. Additional testing should be performed if necessary to differentiate B. holmesii and B. pertussis. B. bronchiseptica is a rare cause of infection in humans. When clinical factors suggest that B. pertussis may not be the cause of respiratory infection, other clinically appropriate investigation(s) should be carried out in accordance with published guidelines. Negative results for the Alethia Pertussis DNA Amplification Assay do not preclude Bordetella pertussis infection and positive results do not rule out co-infection with other respiratory pathogens. Results from the Alethia Pertussis assay should be used in conjunction with information obtained during the patient’s clinical evaluation as an aid in diagnosis of B. pertussis infection and should not be used as the sole basis for treatment or other patient management decisions. Alethia Pertussis is intended for use in hospital, reference or state laboratory settings. The device is not intended for point-of-care use.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 008407331ALETHIACLC011RE registered 15 Sep 2026 Active
- FDA GUDID UDI-DI 00840733102226 listed 8 Jan 2019 Listed
Timeline
- Listed FDA GUDID 00840733102226
- Registered EUDAMED 008407331ALETHIACLC011RE
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- alethia® Pertussis EUDAMEDAlethia™ Pertussis GUDID
- Generic name
- Bordetella pertussis nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 480750
- Primary DI / UDI-DI
- 00840733102226
- Basic UDI-DI
- 008407331ALETHIACLC011RE
- Direct marketing DI
- 00840733102226
- FDA product code
- OZZ
- EMDN code
- W0105011607 Bordetella pertussis / parapertussis - na reagents
- GMDN term
- Bordetella pertussis nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class C EUDAMEDClass II GUDID
- Regulation number
- 866.3980
- EU registration type
- Standard device
- EU market of registration
- Italy
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class C | Class II |
Similar devices in this category
Other devices filed under OTHER BACTERIOLOGY - NA REAGENTS.
- BIOSYNEX AMPLIQUICK Bordetella 3150068_SEC02 by BIOSYNEX
- Drug Resistant Bordetella pertussis Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) S3136E-24 by Sansure Biotech Inc.
- Bordetella Pertussis DNA Diagnostic Kit (PCR-Fluorescence Probing) S3055E by Sansure Biotech Inc.
- ChainFor™ PCR07 by Vitrosens Biotechnology Inc.
- LyoSens Yersinia enterocolitica Detection qPCR Kit LYO06 by Vitrosens Biotechnology Inc.
- Real-time PCR Detection Kit for Shigella Strains A2070 by Beijing Applied Biological Technologies Co., Ltd.
- BD MAX™ Extended Enteric Bacterial Panel 443812 by Becton, Dickinson and Company
- BD Vaginal Panel on BD COR System 443976 by Becton, Dickinson and Company
- RevoDx Haemophilus influenzae qPCR Kit IP202252-500 by İDİL BİOTECH ARAŞTIRMA SAN. VE TİC. LTD. ŞTİ.
- Real-time PCR Detection Kit for Vibrio Cholerae Nucleic Acid ID051 by Beijing Applied Biological Technologies Co., Ltd.